DE PALMA, Raffaele
 Distribuzione geografica
Continente #
EU - Europa 2.716
NA - Nord America 2.440
AS - Asia 444
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
OC - Oceania 2
SA - Sud America 1
Totale 5.610
Nazione #
US - Stati Uniti d'America 2.437
IE - Irlanda 854
UA - Ucraina 445
GB - Regno Unito 360
IT - Italia 236
FR - Francia 225
DE - Germania 213
SE - Svezia 159
TR - Turchia 146
CN - Cina 136
SG - Singapore 120
FI - Finlandia 116
GR - Grecia 83
KR - Corea 27
BE - Belgio 14
VN - Vietnam 10
ES - Italia 4
EU - Europa 4
HR - Croazia 3
CA - Canada 2
CH - Svizzera 2
NG - Nigeria 2
AL - Albania 1
AU - Australia 1
BR - Brasile 1
EG - Egitto 1
IN - India 1
IR - Iran 1
JP - Giappone 1
MX - Messico 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
TW - Taiwan 1
Totale 5.610
Città #
Dublin 854
Jacksonville 682
Chandler 441
Princeton 126
Medford 102
Ann Arbor 80
Boardman 74
Roxbury 70
Singapore 65
Wilmington 65
Caserta 63
San Mateo 63
Woodbridge 55
Beijing 42
Cambridge 35
Bremen 31
Des Moines 29
Düsseldorf 26
Ashburn 23
Nanjing 22
Napoli 22
New York 18
Mountain View 17
Norwalk 16
Brussels 14
Los Angeles 14
Genova 12
Dong Ket 10
Nanchang 10
Seoul 10
Auburn Hills 9
Houston 9
Jinan 9
Munich 9
Redwood City 9
Helsinki 8
Seattle 8
Kunming 7
Naples 6
Rome 6
Dipignano 5
Florence 5
Tianjin 5
Venice 5
Capaccio 4
Motilla Del Palancar 4
Ningbo 4
Orange 4
Redmond 4
Stanford 4
Taiyuan 4
Boston 3
Changsha 3
Fairfield 3
Falls Church 3
Guangzhou 3
Haikou 3
Hangzhou 3
Sennori 3
Shenyang 3
Walnut 3
Angri 2
Anzio 2
Dearborn 2
Hanover 2
Hatfield 2
Jiaxing 2
Lanzhou 2
Marano Di Napoli 2
Milan 2
Olgiate Comasco 2
Ottawa 2
Padova 2
Santa Maria Capua Vetere 2
Tappahannock 2
Torino 2
Vicenza 2
Volta Mantovana 2
Zhengzhou 2
Zurich 2
Andover 1
Arlington Heights 1
Arzano 1
Auckland 1
Bollebygd 1
Borås 1
Brisbane 1
Cairo 1
Casoria 1
Changchun 1
Conegliano 1
Forest City 1
Giugliano In Campania 1
Gunzenhausen 1
Harbin 1
Hefei 1
Hendon 1
Ibstock 1
Istanbul 1
Karachi 1
Totale 3.307
Nome #
C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes. 101
Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal Antibody Can Be Overcome by Combined Treatment of Regorafenib with Cetuximab. 86
Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells 86
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. 80
Transcoronary Th-17 lymphocytes and acute coronary syndromes: new evidence from the crime scene? 76
Uso e preparazione di glicolipidi come adiuvanti in vaccini, Brevetto US Patent 20,160,151,483, 2016 74
Uso e prepaprazione di una nuova classe di Glicolipidi come adiuvanti per vaccini 72
B cell depletion with Rituximab in relapsing-remitting multiple sclerosis 71
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors 71
Intratracheal administration of mesenchymal stem cells modulates tachykinin system, suppresses airway remodeling and reduces airway hyperresponsiveness in an animal model 67
Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: evidence for a local, intracoronary immunologic mechanism. 66
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation 66
Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells. 62
Activation of protease-activated receptor-2 reduces airways inflammation in experimental allergic asthma. 62
The involvement of sensory neuropeptides in airway hyper-responsiveness in rabbits sensitized and challenged to Parietaria judaica 60
Alteration of Th17 and Treg populations coexist in patients affected with systemic sclerosis 59
Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells 58
Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors 58
Systemic Administration of Sphingosine-1-phosphate Increases Bronchial Hyper-Responsiveness in the Mouse 56
Senescence and NF-kappaB: a trojan horse in tumors? 56
Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes 55
Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients 55
Human eosinophil chemotaxis and selective in vivo recruitment by sphingosine 1-phosphate. 55
Analysis of the antigen specific T cell repertoires in HIV infection 55
Antagonistic T-Cell subsets in skin diseases 55
Involvement of proteinase activated receptor-2 in the vascular response to sphingosine 1-phosphate. 54
Autologous Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed nasopharingeal carcinoma 53
IL-4-induced gene 1 maintains high Tob1 expression that contributes to TCR unresponsiveness in human T helper 17 cells. 52
Major histocompatibility complex-independent recognition of a distinctive pollen antigen, most likely a carbohydrate, by human CD8+ alpha/beta T cells 52
Peripheral T lymphocytes from patients with early systemic sclerosis co-cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin 52
Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation 52
Comparative analysis of new innovative vaccine formulations based on the use of procaryotic display systems 52
Use of altered peptide ligands to modulate immune responses as a possible immunotherapy for allergies 52
Cytokine expression in chronically rejected kidney allografts 52
New Role of Adult Lung c-kit+ Cells in a Mouse Model of Airway Hyperresponsiveness 52
Early Systemic Sclerosis: Serum Profiling of Factors Involved in Endothelial, T-cell, and Fibroblast Interplay is Marked by Elevated Interleukin-33 Levels. 51
CD4+CD161+ T cells showing transient nature of the Th17 phenotype are present in the synovial fluid from patients with juvenile idiopathic arthritis 51
Immune-inflammatory activation in acute coronary syndromes: A look into the heart of unstable coronary plaque 51
Sphingosine-1-phosphate/sphingosine kinase pathway is involved in mouse airway hyperresponsiveness. 50
Adult SURF Study Group. A survey of clinical features of allergic rhinitis in adults 50
Upregulation of TH/IL-17 Pathway-Related Genes in Human Coronary Endothelial Cells Stimulated with Serum of Patients with Acute Coronary Syndromes 50
Sphingosine 1-Phosphate Induces Endothelial Nitric-Oxide Synthase Activation through Phosphorylation in Human Corpus Cavernosum 49
Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution 49
Tat protein is an HIV-1-encoded beta-chemokine homolog that promotes migration and up-regulates CCR3 expression on human Fc epsilon RI+ cells 49
Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients 49
Use of antagonist peptides to inhibit in vitro T cell responses to Par j1, the major allergen of Parietaria judaica pollen 48
Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation. 48
A chemical investigation on the Antarctic sponge Lyssodendoryx flabellata 48
A flavonoid sulfate antigen activates human alphabeta CD8+ Th2 lymphocytes in pollen allergy 48
HDAC inhibitors as epigenetic regulators for cancer immunotherapy 48
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer 48
Demethylation of the RORC2 and IL17A in human CD4+ T lymphocytes defines Th17 origin of nonclassic Th1 cells. 47
The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation 47
beta(3) Integrin subunit mediates the bone-resorbing function exerted by cultured myeloma plasma cells 47
Tolerance of host and donor cells in persistent chimerism after bone marrow transplantation is characterized by the expansion of several T cell populations and by Th2-like production of cytokines. 47
JAK2 is overexpressed in human multiple sclerosis Th17 cells and stabilizes cell surface expression of IFN-{gamma} R2 47
NF-κB-dependent cytokine secretion controls Fas expression on chemotherapy-induced premature senescent tumor cells 46
Peripheral blood mononuclear cells (PBMCs) of systemic sclerosis patients induce apoptosis in cocultured autologous fibroblasts and up-regulate HLA-DR and FASL 46
Rarity of Human T Helper 17 Cells Is due to Retinoic Acid Orphan Receptor-Dependent Mechanisms that Limit Their Expansion. 46
MEK inhibitor as a single agent and in combination with everolimus or sorafenib in a panel of colorectal cancer cell lines: implication for multitargeted approach 46
Distinctive features of classic and nonclassic (Th17 derived) human Th1 cells 46
Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells: an emerging role for urotensin II in cardiovascular disease 45
Human naive CD4 T-cell clones specific for HIV envelope persist for years in vivo in the absence of antigenic challenge 45
The Immune System 45
new mouse model of Peyronie's disease: An increased expression of hypoxia-inducible factor-1 target genes during the development of penile changes 44
Functional changes in scleroderma fibroblasts co-cultured with autologous peripheral blood mononuclear cells (PBMCS) 44
Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines 44
Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis 44
Cross talk between Toll-Like Receptor 4 (TLR4) and Proteinase Activated Receptor 2 (PAR-2) is involved in vascular function. 43
Comparative analysis of cancer vaccine settings for the selection of an effective protocol in mice. 43
Peripheral T cells from patients with early systemic sclerosis kill autologous fibroblasts in co-culture: is T-cell response aimed to play a protective role? 43
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes 43
Oligoclonal T-lymphocyte expansion in human coronary unstable plaques 43
Immunophenotypical and functional characterization of fibroblasts in SSc patients 43
Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: A possible contribution of immunity to thrombosis? 43
Preservation of clonal heterogeneity of the Pneumocystis carinii-specific CD4 T cell repertoire in HIV infected, asymptomatic individuals 42
CROSS-SECTIONAL EVALUATION OF CHEMOKINE PROFILE IN EARLY AND DEFINITE SYSTEMIC SCLEROSIS 42
Human circulating group 2 innate lymphoid cells can express CD154 and promote IgE production 42
Posttransplant human herpes virus 8 infection and seroconversion in a Kaposi's sarcoma affected kidney recipient transplanted from a human herpes virus 8 positive living related donor. 41
Cytotoxic molecule mRNA expression in chronically rejected human kidney allografts 41
Local cytokine production in patients with Acute Coronary Syndromes: a look into the eye of the perfect (cytokine) storm. 40
SURNATANTS FROM SYSTEMIC SCLEROSIS PBMCS CO-CULTURED WITH AUTOLOGOUS FIBROBLASTS DISPLAY HIGH LEVELS OF PRO-FIBROTIC CYTOKINES 40
A new marine-derived sulfoglycolipid triggers dendritic cell activation and immune adjuvant response 40
Th1/Th2 lymphocyte polarization in asthma 39
Neopterin induces pro atherothrombotic phenotype in human coronary endothelial cells 38
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTL) for the treatment of patients with EBV-positive relapsed nasopharingeal carcinoma 38
Nobiletin inhibits oxidized-LDL mediated expression of Tissue Factor in human endothelial cells through inhibition of NF-kappa B 38
Mutual Antagonism of T-cell subsets causing psoriasis and atopic eczema (in skin diseases) 37
Coexistence of two functioning T-cell repertoires in healthy ex-thalassemics bearing a persistent mixed chimerism years after bone marrow transplantation 37
Peripheral Blood Mononuclear Cells Co-Cultured With Autologous Skin Fibroblasts Up-Regulate IL-17A and Play Anti-Fibrotic Effects In Systemic Sclerosis. 37
Role of Th22 expansion in multiple sclerosis disease activity 37
In human multiple sclerosis, T helper 17 lymphocytes display increased levels of JAK2 that stabilize cell surface of IFN-gamma R2 chain 37
Primer in Allergology and Clinical Immunology 37
TGF- indirectly favors the development of human Th17 cells by inhibiting Th1 cells 36
Identification of T cells responding to a self-protein modified by an external agent 36
Th17 Cells in Multiple Sclerosis Express Higher Levels of JAK2, Which Increases Their Surface Expression of IFN-γR2. 36
Thymoma Associated Immunodeficiency: a Syndrome Characterized by Severe Alterations in NK, T- and B-Cells and Progressive Increase in Naïve CD8+ T-Cells 36
FRI0522 Peripheral Blood Mononuclear Cells Co-Cultured with Autologous Skin Fibroblasts Up-Regulate IL-17A and Play Anti-Fibrotic Effects in Systemic Sclerosis 36
Expansion of Th17 cells and IL-17 are present only in a subset of patients with acute coronary syndrome 35
Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients 35
Totale 5.002
Categoria #
all - tutte 24.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.764


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020526 0 0 0 9 118 22 157 43 83 43 39 12
2020/2021951 97 3 121 54 134 6 130 105 9 131 110 51
2021/2022773 71 6 15 29 283 6 13 17 31 24 59 219
2022/20231.589 143 44 26 137 136 130 0 100 814 17 22 20
2023/2024502 55 21 15 63 200 24 0 18 1 5 30 70
2024/202546 4 25 9 8 0 0 0 0 0 0 0 0
Totale 5.771